Biohaven (BHVN) News Today $38.42 -1.35 (-3.40%) As of 01:07 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Peregrine Capital Management LLC Makes New $5.56 Million Investment in Biohaven Ltd. (NYSE:BHVN)Peregrine Capital Management LLC bought a new stake in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 148,879 shares of the company's stock, valued at approximately $5,561,000. Peregrine CapiFebruary 19 at 5:15 AM | marketbeat.comShort Interest in Biohaven Ltd. (NYSE:BHVN) Drops By 5.0%February 19 at 3:23 AM | americanbankingnews.comBiohaven Ltd. (NYSE:BHVN) Sees Large Decrease in Short InterestBiohaven Ltd. (NYSE:BHVN - Get Free Report) was the recipient of a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 9,440,000 shares, a decline of 5.0% from the January 15th total of 9,940,000 shares. Based on an average trading volume of 972,100 shares, the days-to-cover ratio is currently 9.7 days.February 18 at 1:51 AM | marketbeat.comBrokerages Set Biohaven Ltd. (NYSE:BHVN) Target Price at $63.15February 18 at 1:13 AM | americanbankingnews.comBiohaven Ltd. (NYSE:BHVN) Receives Consensus Rating of "Buy" from AnalystsBiohaven Ltd. (NYSE:BHVN - Get Free Report) has received an average rating of "Buy" from the fifteen brokerages that are covering the firm, Marketbeat reports. Fourteen analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The avFebruary 15, 2025 | marketbeat.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Biohaven Ltd. (BHVN), Arrowhead Pharmaceuticals (ARWR) and Arvinas Holding Company (ARVN)February 13, 2025 | markets.businessinsider.comBiohaven Ltd. Receives FDA Priority Review for Troriluzole, Boosting Investor ConfidenceFebruary 13, 2025 | tipranks.comDeutsche Bank Initiates Coverage of Biohaven (BHVN) with Buy RecommendationFebruary 12, 2025 | msn.comWhy Biohaven Stock Triumphed on TuesdayFebruary 11, 2025 | fool.comBiohaven: NDA Review Of Troriluzole Isn't Only 2025 Catalyst On DeckFebruary 11, 2025 | seekingalpha.comBiohaven's troriluzole krijgt voorrangsbehandeling van FDA voor SCAFebruary 11, 2025 | nl.investing.comBiohaven aandeel stijgt na FDA-beoordeling en Deutsche Bank koopadviesFebruary 11, 2025 | nl.investing.comWhy Biohaven (BHVN) Stock Is Rallying TodayFebruary 11, 2025 | msn.comBiohaven Ltd.: Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar AtaxiaFebruary 11, 2025 | finanznachrichten.deBiohaven: Highly Priced Biotech With Broad Pipeline But No RevenuesFebruary 11, 2025 | seekingalpha.comBiohaven's troriluzole gains FDA priority review for SCAFebruary 11, 2025 | msn.comBiohaven’s troriluzole NDA in spinocerebellar ataxia accepted by the FDAFebruary 11, 2025 | markets.businessinsider.comBiohaven stock rises following FDA review and Deutsche Bank's buy ratingFebruary 11, 2025 | msn.comBiohaven (NYSE:BHVN) Shares Gap Up - What's Next?Biohaven (NYSE:BHVN) Shares Gap Up - Still a Buy?February 11, 2025 | marketbeat.comBiohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar AtaxiaFebruary 11, 2025 | prnewswire.comDeutsche Bank Aktiengesellschaft Initiates Coverage on Biohaven (NYSE:BHVN)Deutsche Bank Aktiengesellschaft initiated coverage on Biohaven in a research note on Tuesday. They set a "buy" rating and a $65.00 target price for the company.February 11, 2025 | marketbeat.comDeutsche Bank sets $65 target for Biohaven stock with Buy ratingFebruary 11, 2025 | msn.comBiohaven initiated with a Buy at Deutsche BankFebruary 11, 2025 | markets.businessinsider.comWCM Investment Management LLC Makes New Investment in Biohaven Ltd. (NYSE:BHVN)WCM Investment Management LLC acquired a new stake in Biohaven Ltd. (NYSE:BHVN - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 106,665 shares of the company's stock, valued at apprFebruary 10, 2025 | marketbeat.comJennison Associates LLC Purchases New Shares in Biohaven Ltd. (NYSE:BHVN)Jennison Associates LLC acquired a new position in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 97,532 shares of the company's stock, valued at appFebruary 7, 2025 | marketbeat.comSG Americas Securities LLC Has $336,000 Holdings in Biohaven Ltd. (NYSE:BHVN)SG Americas Securities LLC cut its holdings in Biohaven Ltd. (NYSE:BHVN - Free Report) by 45.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,001 shares of the company's stock after selling 7,529February 5, 2025 | marketbeat.comBiohaven Ltd.’s Promising Outlook for Troriluzole in Spinocerebellar Ataxia Amidst FDA DecisionFebruary 5, 2025 | tipranks.comChina Universal Asset Management Co. Ltd. Makes New $575,000 Investment in Biohaven Ltd. (NYSE:BHVN)China Universal Asset Management Co. Ltd. purchased a new stake in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 15,396 shares of the comFebruary 3, 2025 | marketbeat.comFY2025 EPS Estimates for Biohaven Cut by Leerink PartnrsBiohaven Ltd. (NYSE:BHVN - Free Report) - Equities research analysts at Leerink Partnrs dropped their FY2025 earnings per share estimates for Biohaven in a research report issued on Wednesday, January 29th. Leerink Partnrs analyst M. Goodman now anticipates that the company will earn ($6.90) perJanuary 31, 2025 | marketbeat.comPfizer settles Biohaven kickback case with DOJ for $60MJanuary 24, 2025 | msn.comBrokers Offer Predictions for Biohaven FY2025 EarningsBiohaven Ltd. (NYSE:BHVN - Free Report) - Investment analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for Biohaven in a research note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst C. Duncan expects that the company will post earnings per share of ($6.January 22, 2025 | marketbeat.comARS Investment Partners LLC Has $38.87 Million Position in Biohaven Ltd. (NYSE:BHVN)ARS Investment Partners LLC increased its position in Biohaven Ltd. (NYSE:BHVN - Free Report) by 1.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,040,712 shares of the company'sJanuary 21, 2025 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Given Average Rating of "Buy" by BrokeragesShares of Biohaven Ltd. (NYSE:BHVN - Get Free Report) have been given an average rating of "Buy" by the fourteen analysts that are presently covering the company, Marketbeat Ratings reports. Thirteen research analysts have rated the stock with a buy recommendation and one has assigned a strong buJanuary 21, 2025 | marketbeat.comBiohaven (NYSE:BHVN) Trading Down 6.4% - Here's What HappenedBiohaven (NYSE:BHVN) Stock Price Down 6.4% - Time to Sell?January 16, 2025 | marketbeat.comBernstein Sticks to Their Buy Rating for Biohaven Ltd. (BHVN)January 14, 2025 | markets.businessinsider.comPiper Sandler Remains a Buy on Biohaven Ltd. (BHVN)January 14, 2025 | markets.businessinsider.comBiohaven (NYSE:BHVN) Stock Price Down 6.4% - Time to Sell?Biohaven (NYSE:BHVN) Stock Price Down 6.4% - Time to Sell?January 14, 2025 | marketbeat.comBiohaven announces 2025 anticipated milestonesJanuary 13, 2025 | markets.businessinsider.comBiohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generation Potential Therapy for IgA NephropathyJanuary 13, 2025 | prnewswire.comBiohaven (NYSE:BHVN) Shares Gap Down - Here's What HappenedBiohaven (NYSE:BHVN) Shares Gap Down - What's Next?January 10, 2025 | marketbeat.comBiohaven to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 7, 2025 | prnewswire.comBernstein Sticks to Its Buy Rating for Biohaven Ltd. (BHVN)January 7, 2025 | markets.businessinsider.comBiohaven Ltd. (NYSE:BHVN) Holdings Raised by JPMorgan Chase & Co.JPMorgan Chase & Co. raised its stake in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) by 85.4% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 809,448 shares of the company's stock after buying an additional 372,737 shJanuary 6, 2025 | marketbeat.comThe Last 12 Months Of Insider Transactions At BiohavenJanuary 3, 2025 | finance.yahoo.comBiohaven Ltd. (NYSE:BHVN) Director John W. Childs Purchases 29,000 SharesJanuary 1, 2025 | insidertrades.comBiohaven-directeur John Childs verwerft aandelen ter waarde van $1,04 miljoenDecember 31, 2024 | nl.investing.comBiohaven Stock Surges After Director Acquires Shares Worth Over $1M: Retail Sentiment Turns BullishDecember 31, 2024 | msn.comBiohaven (NYSE:BHVN) Shares Gap Up on Insider Buying ActivityBiohaven (NYSE:BHVN) Shares Gap Up After Insider Buying ActivityDecember 31, 2024 | marketbeat.comJohn W. Childs Buys 29,000 Shares of Biohaven Ltd. (NYSE:BHVN) StockBiohaven Ltd. (NYSE:BHVN - Get Free Report) Director John W. Childs purchased 29,000 shares of Biohaven stock in a transaction dated Monday, December 30th. The stock was bought at an average price of $35.94 per share, for a total transaction of $1,042,260.00. Following the completion of the purchase, the director now owns 2,368,741 shares in the company, valued at $85,132,551.54. This represents a 1.24 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.December 31, 2024 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Given Average Rating of "Buy" by AnalystsShares of Biohaven Ltd. (NYSE:BHVN - Get Free Report) have received a consensus recommendation of "Buy" from the fourteen research firms that are currently covering the firm, Marketbeat reports. Thirteen investment analysts have rated the stock with a buy rating and one has given a strong buy ratiDecember 27, 2024 | marketbeat.com Get Biohaven News Delivered to You Automatically Sign up to receive the latest news and ratings for BHVN and its competitors with MarketBeat's FREE daily newsletter. Email Address BHVN Media Mentions By Week BHVN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BHVN News Sentiment▼0.990.60▲Average Medical News Sentiment BHVN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BHVN Articles This Week▼66▲BHVN Articles Average Week Get Biohaven News Delivered to You Automatically Sign up to receive the latest news and ratings for BHVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Summit Therapeutics News Genmab A/S News Intra-Cellular Therapies News Viatris News Moderna News Dr. Reddy's Laboratories News Vaxcyte News Sarepta Therapeutics News Qiagen News Ascendis Pharma A/S News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BHVN) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biohaven Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biohaven With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BHVN Stock Alerts